- Home
- ZION vs BRKR Comparison
ZION vs BRKR Comparison
Compare ZION & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZION | BRKR |
|---|---|---|
| Founded | 1873 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 8.6B |
| IPO Year | 2012 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ZION | BRKR |
|---|---|---|
| Price | $66.31 | $57.61 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 23 | 13 |
| Target Price | ★ $72.73 | $63.83 |
| AVG Volume (30 Days) | 1.4M | ★ 2.1M |
| Earning Date | 10-19-2026 | 11-04-2026 |
| Dividend Yield | ★ 2.89% | 0.35% |
| EPS Growth | ★ 21.41 | N/A |
| EPS | ★ 4.61 | N/A |
| Revenue | $662,000,000.00 | ★ $1,895,600,000.00 |
| Revenue This Year | $5.90 | $3.48 |
| Revenue Next Year | $2.31 | $4.16 |
| P/E Ratio | $14.38 | ★ N/A |
| Revenue Growth | ★ 3.60 | N/A |
| 52 Week Low | $48.50 | $32.37 |
| 52 Week High | $73.34 | $66.45 |
Technical Indicators
Market Signals| Indicator | ZION | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 62.02 | 46.85 |
| Support Level | $66.17 | $53.89 |
| Resistance Level | $70.70 | $63.77 |
| Average True Range (ATR) | 1.25 | 3.22 |
| MACD | 0.65 | -0.18 |
| Stochastic Oscillator | 92.33 | 24.51 |
Price Performance
Historical ComparisonAbout ZION Zions Bancorporation N.A.
Zions Bancorp is a US regional bank with around $90 billion in total assets as of Sept. 30, 2025. Headquartered in Salt Lake City, Utah, Zions' branch network is in the Western and Southwestern United States and includes seven affiliate banks in these markets. The bank has a heavy focus on small and midsize commercial banking.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.